feed,title,long_url,short_url
Benzinga,Five-Year Data Of BioMarin's Hemophilia Gene Therapy Shows Sustained Benefit,https://benzinga.com/general/biotech/21/05/21196649/five-year-data-of-biomarins-hemophilia-gene-therapy-shows-sustained-benefit,https://j.mp/3v1GmHn
